Search the Newsreel

Is HA Sustainable Infrastructure Capital (HASI) Undervalued On Its Q2 Earnings Beat?

HA Sustainable Infrastructure Capital, Inc. to Issue Quarterly Dividend of $0.42 (NYSE:HASI)

HA Sustainable Infrastructure Capital, Inc. (NYSE:HASI) has announced a quarterly dividend of $0.425 per share, payable on October 16th to shareholders of record as of October 2nd. This dividend represents an annualized yield of 4.4% and is well-covered by the company's earnings, with an …

Silver Pegasus Acquisition Corp (SPEG) Stock News Today

Tarsus Pharmaceuticals, Inc. 2026 Q2 - Results - Earnings Call Presentation (NASDAQ:TARS) 2026-08-06

Tarsus Pharmaceuticals, Inc. (TARS) published its Q2 2026 earnings call presentation on August 6, 2026. The company reported an EPS of -$0.43, missing estimates by $0.23, while revenue reached $173.91M, beating expectations by $4.40M and showing a 69.41% year-over-year increase. This article includes the …

HA Sustainable Infrastructure (NYSE: HASI) posts higher Q2 2026 profit

Consensus Cloud Solutions (Nasdaq: CCSI) lifts Q2 net income to $27,374

Consensus Cloud Solutions (Nasdaq: CCSI) reported a significant increase in Q2 2026 net income, reaching $27,374 (in thousands), up from $20,781 (in thousands) in the prior year. Revenue grew 4% year-over-year to $91,361 (in thousands), primarily driven by a 9% increase in Corporate revenue, …

Kan het aandeel Prosus de winst verder uitbreiden nu kopers richting de weerstand op €43,13 duwen?

HA Sustainable Infrastructure Capital, Inc. $HASI Shares Acquired by California State Teachers Retirement System

The California State Teachers Retirement System increased its stake in HA Sustainable Infrastructure Capital, Inc. ($HASI) by 24.5% in the first quarter, acquiring an additional 28,834 shares, bringing its total to 146,396 shares valued at $5.38 million. Institutional ownership of HASI remains high at …

Consensus Cloud Solutions, Inc. 2026 Q2 - Results - Earnings Call Presentation (NASDAQ:CCSI) 2026-08-07

Royal Bank of Canada Cuts Stock Holdings in HA Sustainable Infrastructure Capital, Inc. $HASI

Royal Bank of Canada reduced its stake in HA Sustainable Infrastructure Capital, Inc. (NYSE:HASI) by 8.7% in the first quarter, selling 62,463 shares but still retaining 655,489 shares valued at $24.1 million. Despite this reduction, institutional ownership in HASI remains high at 96.14%, with …

Form 8K Consensus Cloud Solutions Inc For: 6 August By Investing.com

This article reports on a Form 8K filing by Consensus Cloud Solutions Inc. for August 6th. The brief news item also mentions the stock symbol CCSI and its recent price performance. It is a very short announcement from Investing.com with no additional details.

Consensus Cloud Solutions (NASDAQ:CCSI) Updates FY 2026 Earnings Guidance

Press Release: Tarsus Pharmaceuticals Announces Oversubscribed $125.0 Million Private Placement Equity Financing

Tarsus Pharmaceuticals announced an oversubscribed private placement equity financing of $125.0 million. The financing is led by new and existing institutional investors, including Fidelity Management & Research Company LLC, RA Capital Management, and Eventide Asset Management. The proceeds are intended to fund the continued …

HA Sustainable Infrastructure Capital (HASI) Tops Q2 Earnings and Revenue Estimates

HA Sustainable Infrastructure Capital (HASI) came out with quarterly earnings of $0.75 per share, beating the Zacks Consensus Estimate of $0.73 per share. This compares to earnings of $0.6 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report …

HA Sustainable Infrastructure Capital (NYSE:HASI) Updates FY 2026 Earnings Guidance

HA Sustainable Infrastructure Capital (NYSE:HASI) has updated its FY 2026 earnings guidance, projecting EPS between $3.55 and $3.65, significantly above the analyst consensus of $2.71. This follows a strong quarterly performance where the company exceeded revenue and EPS expectations. Analysts maintain a generally positive …

Latham & Watkins Advises Alkeus Pharmaceuticals on Acquisition by Tarsus Pharmaceuticals

Latham & Watkins LLP advised Alkeus Pharmaceuticals on its acquisition by Tarsus Pharmaceuticals, Inc. The deal, announced on July 31, 2026, involves Tarsus acquiring Alkeus, a privately held retinal disease-focused biotechnology company developing gildeuretinol (ALK-001) for Stargardt disease. A comprehensive legal team from Latham …

HA Sustainable Infrastructure Capital (NYSE:HASI) Reports Strong Q2 CY2026

HA Sustainable Infrastructure Capital (NYSE:HASI) Reports Strong Q2 CY2026 Climate investment firm HA Sustainable Infrastructure Capital (NYSE:HASI) reported Q2 CY2026 results beating Wall Street's revenue expectations , with sales up 16.6% year on year to $120.8 million. Its non-GAAP profit of $0.75 per share …

Form 8K Hannon Armstrong Sustainable Infrastructure Capital Inc For: 6 August By Investing.com

This article announces the filing of a Form 8K by Hannon Armstrong Sustainable Infrastructure Capital Inc. on August 6. It also mentions the company's stock symbol, HASI, and its current performance with a slight increase of 0.18%. The rest of the content includes market …

BRIEF-Consensus Cloud Solutions Q2 EPS USD 1.43

Consensus Cloud Solutions reported its Q2 earnings per share (EPS) of USD 1.43. This brief announcement from Reuters indicates the company's financial performance for the second quarter. The full article is available through a TradingView subscription.

Consensus Cloud Solutions, Inc. Reports Second Quarter 2026 Results; Reaffirms Full Year 2026 and Releases Q3 2026 Guidance; Increases Stock Buyback Program to $200 Million

Consensus Cloud Solutions, Inc. reported strong financial results for Q2 2026, with revenues increasing by 4.1% to $91.4 million and net income rising by 31.7% to $27.4 million. The company reaffirmed its full-year 2026 guidance, provided Q3 2026 guidance, and increased its stock buyback …

HASI Announces Second Quarter 2026 Results and Raises Guidance on 24% Y/Y Adjusted EPS Growth YTD and Adjusted ROE Above 15%

ANNAPOLIS, Md., August 06, 2026--(BUSINESS WIRE)--HA Sustainable Infrastructure Capital, Inc. ("HASI," "we," "our" or the "Company") (NYSE: HASI), a leading investor in sustainable infrastructure assets, today reported results for the second quarter of 2026. Key Highlights GAAP EPS of $0.92, compared with $0.74 in …

Tarsus to purchase Alkeus Pharmaceuticals

Tarsus Pharmaceuticals plans to acquire Alkeus Pharmaceuticals, including its late-stage investigational therapy for Stargardt disease, gildeuretinol acetate (ALK-001). The deal involves an estimated $450 million upfront consideration in cash and stock, plus potential future milestones and royalties. ALK-001 has received multiple FDA designations and …

Consensus Cloud Solutions (NASDAQ: CCSI) lifts Q2 profit, expands $200M buyback

Consensus Cloud Solutions (NASDAQ: CCSI) reported a strong Q2 2026, with revenue increasing by 4.1% to $91.4 million and net income jumping 31.7% to $27.4 million. Diluted EPS rose 33.6% to $1.43, driven by revenue growth and an unrealized investment gain. The company also …

Hannon Armstrong sustainable infrastructure earnings up next By Investing.com

Hannon Armstrong Sustainable Infrastructure Capital Inc. is expected to report its second-quarter earnings today, with analysts anticipating 74 cents per share on revenue of $110.8 million. While this marks a sequential decline from Q1, it represents strong year-over-year growth. Investors will be focused on …

Tarsus Pharmaceuticals Inc (TARS) (Q2 2026) Earnings Call Highlights: Record XDEMVY Sales and ...

This article first appeared on GuruFocus. Release Date: August 06, 2026 For the complete transcript of the earnings call, please refer to the full earnings call transcript. Positive Points Tarsus Pharmaceuticals Inc (NASDAQ:TARS) reported record second-quarter 2026 net product sales of $173.9 million for …

Tarsus Pharmaceuticals, Inc. Stock 12‑Month Price Target Cut to $93.57, Implies 53% Upside

Tarsus Pharmaceuticals, Inc.'s average 12-month stock price target has been lowered slightly from $94.22 to $93.57 by 7 analysts, with individual forecasts ranging from $84 to $104 per share. Based on the August 5th closing price, this updated target suggests a potential upside of …

Consensus Cloud Solutions, Inc. Provides Earnings Guidance for the Third Quarter and Full Year 2026

Consensus Cloud Solutions, Inc. (CCSI) has released its earnings guidance for the third quarter and full fiscal year 2026. For Q3 2026, the company anticipates revenue to be between $89.2 million and $93.2 million. The full-year 2026 revenue guidance is set at a range …

Tarsus Pharmaceuticals, Inc. (TARS) Reports Q2 Loss, Tops Revenue Estimates

Tarsus Pharmaceuticals (TARS) reported a Q2 loss of $0.43 per share, exceeding the Zacks Consensus Estimate of a $0.21 loss, but surpassed revenue expectations with $173.91 million. Despite consistently beating revenue estimates, the stock has underperformed the S&P 500 year-to-date, and its current Zacks …

Tarsus Pharmaceuticals, Inc.

Tarsus Pharmaceuticals announced its plan to acquire Alkeus Pharmaceuticals in a deal valued at up to $800 million. This acquisition will expand Tarsus's eye disease pipeline by adding an experimental oral therapy for a rare inherited retinal disorder for which there is currently no …

Earnings To Watch: Consensus Cloud Solutions Inc (CCSI) Q2 2026 -- GF Value Sees 35% Downside

Consensus Cloud Solutions Inc (CCSI) is scheduled to release its Q2 2026 earnings on August 6, 2026, with revenue and earnings per share estimates of $89.63 million and $1.25 respectively. Analyst price targets suggest a slight downside of -1.07% from its current price, while …

Tarsus Pharmaceuticals To Acquire Alkeus Pharmaceuticals

(RTTNews) - Tarsus Pharmaceuticals, Inc (TARS), a biopharmaceutical company focused on eye care, has entered into a definitive agreement to acquire Alkeus Pharmaceuticals, Inc., a retinal disease-focused biotechnology company. Alkeus' lead candidate Gildeuretinol (ALK-001), an investigational once-daily oral therapy in Phase 3 development for …

Tarsus Pharmaceuticals (TARS) boosts H1 2026 revenue and turns operating cash flow positive

Tarsus Reports Second Quarter 2026 Financial Results, Advances Next Phase of Growth

Tarsus Pharmaceuticals, Inc Generated second quarter 2026 XDEMVY® net product sales of $173.9 million, an increase of more than 69% year-over-year Increased full-year 2026 XDEMVY net product sales guidance to $685-705 million Pending acquisition of Alkeus Pharmaceuticals to expand Tarsus' retina pipeline with a …

Tarsus to Raise About $125M, Selling Stock at $56 a Share

Tarsus Pharmaceuticals announced an oversubscribed private placement (PIPE) expected to generate approximately $125.0 million in gross proceeds. The company will sell 2,098,519 shares of common stock at $56.00 per share and pre-funded warrants for 133,625 shares. The financing includes participation from both existing and …

HA Sustainable Infrastructure Capital, Inc. (NYSE:HASI) Receives Consensus Recommendation of "Moderate Buy" from Brokerages

HA Sustainable Infrastructure Capital, Inc. (NYSE:HASI) has received a consensus "Moderate Buy" rating from twelve brokerages, with an average 12-month price target of $46.90, suggesting potential upside from its current share price of $38.24. The company recently surpassed earnings expectations, reporting $0.77 EPS against …

Hannon Armstrong Sustainable earnings beat by $0.01, revenue topped estimates